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Kruppel-Like Factor KLF4 Facilitates Cutaneous
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Mitzi Nagarkatti1, Daping Fan6 and Walden Ai1
Pressure ulcers (PUs) are serious skin injuries whereby the wound healing process is frequently stalled in the
inflammatory phase. Myeloid-derived suppressor cells (MDSCs) accumulate as a result of inflammation and
promote cutaneous wound healing by mechanisms that are not fully understood. Recently, MDSCs have been
shown to differentiate into fibrocytes, which serve as emerging effector cells that enhance cell proliferation in
wound healing. We postulate that in wound healing MDSCs not only execute their immunosuppressive function
to regulate inflammation but also stimulate cell proliferation once they differentiate into fibrocytes. In the current
study, by using full-thickness and PU mouse models, we found that Kruppel-like factor 4 (KLF4) deficiency resulted
in decreased accumulation of MDSCs and fibrocytes, and wound healing was significantly delayed. Conversely,
KLF4 activation by the plant-derived product Mexicanin I increased the number of MDSCs and fibrocytes and
accelerated the wound healing. Collectively, our study revealed a previously unreported function of MDSCs in
cutaneous wound healing and identified Mexicanin I as a potential agent to accelerate PU wound healing.
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INTRODUCTION
A pressure ulcer (PU) is defined as an injury caused by
unrelieved pressure resulting in damage to the skin and
underlying tissue (Black et al., 2011). Wound healing is a
complex process that includes an early inflammatory phase
and subsequent proliferative and maturative phases (Li et al.,
2005; Kondo and Ishida, 2010; Shih et al., 2010). However,
this process is frequently stalled in the inflammatory phase in
PU (Gist et al., 2009), resulting in chronic wounds. Therefore,
a better understanding of how to control inflammation in
wound healing will lead to the therapeutic strategies that will
potentially improve the quality of life of PU patients.
Myeloid-derived suppressor cells (MDSCs) are a heterogenous
population of bone marrow (BM)-derived cells that bear mono-
cyte markers and possess phenotypic plasticity (Manjili, 2012).
They are broadly defined as Ly6GþCD11bþ cells in mice,
with a wider range of markers in humans. MDSCs are charac-
terized by their potent ability to suppress immune responses,
especially T-cell proliferation and cytokine production
(Gabrilovich and Nagaraj, 2009). Although MDSCs have been
shown to be beneficial to the wound healing process (Cuenca
et al., 2011; Mahdipour et al., 2011; Zhang et al., 2011), the
mechanisms remain unknown. Recent reports indicated that
MDSCs have a high potential of differentiating into fibrocytes
(Niedermeier et al., 2009). Fibrocytes are emerging effector cells
in a chronic inflammation (Reilkoff et al., 2011), which enhance
keratinocyte proliferation in wound healing (Kao et al., 2011).
Therefore, we postulate that in wound healing the recruited
MDSCs not only execute their immunosuppressive function to
keep inflammation in check but also stimulate cell proliferation
once they differentiate into fibrocytes, as suggested by the pre-
sence of fibrocytes during the latter phase of the inflammatory
process (Mori et al., 2005; Fan et al., 2011).
Kruppel-like factor 4 (KLF4) is a transcription factor (Garrett-
Sinha et al., 1996; Shields et al., 1996; Yet et al., 1998) that is
critical to monocyte differentiation (Feinberg et al., 2007;
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Alder et al., 2008). It promotes cutaneous wound healing by
mechanisms that are not clearly delineated (Liao et al., 2011;
Li et al., 2012). We recently reported that KLF4 regulates the
recruitment of MDSCs and the generation of fibrocytes in cancer
development (Yu et al., 2013; Shi et al., 2014). However,
whether KLF4 regulates cutaneous wound healing in an MDSC-
and fibrocyte-dependent manner is not clear. In this study, using
full-thickness and PU mouse models, we show that KLF4
promotes wound healing by regulating the recruitment of
MDSCs and their subsequent differentiation into fibrocytes.
RESULTS
KLF4 ablation resulted in delayed wound healing in a
full-thickness mouse wound healing model
To confirm our observation that KLF4 ablation-delayed cuta-
neous wound healing in tamoxifen-inducible KLF4-CreER/
KLF4(flox) mice (Li et al., 2012), we used RosaCre26ER/
KLF4(flox) double transgenic mice, in which KLF4 was
knocked out following tamoxifen induction in all cells. As
shown in Figures 1a and b, successful KLF4 knockout after
tamoxifen induction was confirmed by immunohistochemical
staining of KLF4 in the skin and by quantitative real-time
reverse-transcriptase–PCR analysis of the expression of KLF4
and its downstream target CCR2 (Alder et al., 2008) in the BM
and spleen. Consistent with a growth inhibitory role of KLF4,
the superbasal layer of the skin in KLF4 knockout mice
(KLF4 / mice) was significantly thicker than that in the
uninduced mice (KLF4þ /þ mice). We then performed the
wound healing experiment in RosaCre26ER/KLF4 (flox) mice
by placing full-thickness wounds (8 mm in diameter) with a
puncher, as previously described (Li et al., 2012). Wound
closure in the KLF4 / group was significantly delayed from
day 3 to day 9 when compared with that in the KLF4þ /þ
group (Figure 1c). We also used immunohistochemistry (IHC)
to examine the expression of a-SMA (a myofibroblast marker)
and COL1A1 (a fibroblast marker) in granulation tissues on
day 3. As expected, their immunoreactivities were both
significantly reduced in the KLF4 / group compared with
the KLF4þ /þ group (Figure 1d).
To examine whether KLF4 deficiency reduces the recruit-
ment of MDSCs in wound healing at day 3, we performed
flow cytometric analysis by using cells purified from BM,
spleen, and the wound site (specific tissue from its edge and
subsurface granulation tissue). Although the percentage of
MDSCs in BM showed no significant difference between the
KLF4þ /þ and KLF4 / groups (data not shown), it was
markedly less in the spleen and the skin wound site in the
KLF4 knockout mice (KLF4 / 8.39±0.82% vs. KLF4þ /þ
14.10±0.92% in spleen, Po0.01; KLF4 / 11.90±0.80%
vs. KLF4þ /þ 15.77±0.52% in skin, Po0.05) (Figure 1e).
KLF4 ablation in bone marrow-delayed cutaneous wound healing
accompanied by decreased accumulation of CCR2þ MDSCs
and fibrocytes in the wound site
To test the possibility that the KLF4 deficiency-induced delay
of cutaneous wound healing is attributable to BM cells, we
performed full-thickness wound healing experiments by using
chimeric mice. These mice were generated by transplant-
ing BM cells from RosaCre26ER/KLF4(flox)/b-actin-enhan-
ced green fluorescent protein (EGFP) triple transgenic mice
into wild-type (WT) C57BL/6 mice. The percentage of EGFP
positivity in circulating leukocytes of the chimeric mice was
490%, as assessed by flow cytometry in tamoxifen-induced
mice (data not shown), suggesting a successful BM reconstitu-
tion. The wound-closure kinetics showed that wound healing
was significantly delayed in the BM KLF4 / group
(Figure 2a). In addition, while the total population of MDSCs
in BM, spleen, and the skin wound site was not significantly
different before and after KLF4 BM knockout by tamoxifen
induction (data not shown), CCR2þ MDSCs in the skin wound
site decreased from 3.29±0.45% in the BM KLF4þ /þ group to
1.61±0.20% in the BM KLF4 / group (Po0.05, Figure 2b).
The generation of fibrocytes from MDSCs shown in recent
studies prompted us to examine the fibrocyte population in
our wound healing model. The results from flow cytometry
revealed that the percentage of BM-derived fibrocytes, char-
acterized as EGFPþCOL1A1þCD45þCD11bþ , decreased
from 10.62±0.94% in the KLF4þ /þ group to 3.96±0.20%
in the KLF4 / group (Po0.01, Figure 2c). This finding was
further confirmed by immunofluorescence staining of skin
cryosections from the wound site; i.e., the numbers of
COL1A1/EGFP and a-SMA/EGFP coexpressing cells in the
KLF4 / group were significantly reduced compared with
those in the control group (Figure 2d).
KLF4-expressing bone marrow cells integrated into the wound
healing tissue and adapted fibroblast morphology in a mouse
wound healing model
To further examine whether KLF4-expressing BM cells are
involved in cutaneous wound healing, we transplanted BM
cells from our KLF4/EGFP transgenic mice, in which KLF4-
expressing cells are labeled with EGFP (Li et al., 2012), to WT
mice and performed full-thickness wound healing experi-
ments. In control mice, BM cells from the WT C57BL/6
mice were transplanted. As shown in Figure 3, EGFPþ cells
were observed in the healing tissue of chimeric mice receiving
KLF4/EGFP BM cells, but not in the control mice. Interestingly,
KLF4/EGFP cells adapted an elongated morphology and
expressed a-SMA, a marker of myofibroblasts which has a
critical role in wound healing (Desmouliere et al., 2005; Hinz
et al., 2012).
KLF4 deficiency in CCR2þ MDSCs decreased fibrocyte
generation in FSP-1-Cre/KLF4(flox) mice
As KLF4 deficiency in BM resulted in delayed wound healing
accompanied by decreased CCR2þMDSCs (Figure 2b), we
postulated that KLF4 in CCR2þ MDSCs directly regulates
cutaneous wound healing. To test this possibility, we gener-
ated a mouse model in which KLF4 was specifically ablated in
CCR2þ MDSCs by crossing KLF4(flox) mice with FSP-1-Cre
mice, because FSP-1 is highly expressed in BM CCR2þ
MDSCs, as shown in our recent studies (Shi et al., 2014).
FSP-1-Cre/KLF4(flox) mice showed no obvious abnormal-
ities from birth to 8 weeks of age. After 8 weeks of age,
significant hair and weight loss was observed in these KLF4-
deficient mice when compared with WT mice (Figure 4a and b).
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Successful KLF4 knockout in monocytes in KLF4-deficient
mice (designated as KLF4 / (FSP-1)) was confirmed by
quantitative real-time reverse-transcriptase–PCR (Supplemen-
tary Figure 1 Online). IHC staining showed that the number of
KLF4-positive cells was decreased by 84% in KLF4 / (FSP-1)
mice (Figure 4c). Hematoxylin and eosin stain staining
showed that the hair follicle density decreased by B50%,
and the suprabasal layer was thicker in KLF4 / (FSP-1)
mice (Figure 4d). To examine the potential immunological
defects in FSP-1-Cre/KLF4 (flox) mice, we measured the
cytokine/chemokine levels in mouse sera. Expression levels
of IL4 and IL5 were significantly increased, but the level of
IL-12 (P40), a shared subunit of IL-12 and IL-23 (Quatresooz
et al., 2012), was decreased in KLF4 / (FSP-1) mice
(Figure 4e). Interestingly, expression levels of granulocyte
colony-stimulating factor and macrophage inflammatory pro-
tein 1 alpha were also significantly increased in KLF4 /
(FSP-1) mice (Figure 4e). Consistent with the importance of
CCR2þ MDSCs in fibrocyte generation (Shi et al., 2014), the
number of fibrocytes generated from the spleen cells decreased
from 112±8 per 105 cells in the WT mice to 46±4 per 105
cells in FSP-1-Cre/KLF4 (flox) mice (Figure 4f).
Compromised wound healing in FSP-1-Cre/KLF4(flox) mice was
associated with decreased accumulation of CCR2þ MDSCs and
fibrocytes in a mouse pressure ulcer model
We used a recently established mouse PU model (Stadler
et al., 2004) to further examine the role of KLF4 in wound
healing with our FSP-1-Cre/KLF4(flox) mice. In this model,
ulcers were typically formed at the end of the third ischemia/
reperfusion cycle and were accompanied by full-thickness loss
of skin. The detached ulcerated skin was removed right after
the third ischemia/reperfusion circle. As shown in Figure 5a,
1 day after the ulcerated skin was removed, the open areas
were increased in both WT and KLF4 / (FSP-1) mice; in all
likelihood, this was related to an acute response. From day 2
to day 10, the wounds were gradually healed in WT mice, but
healing was significantly delayed in KLF4 / (FSP-1) mice.
HE staining showed increases in the suprabasal layer of the
skin and decreases in hair follicle density. In addition, the
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Figure 1. Kruppel-like factor 4 (KLF4) ablation-delayed cutaneous wound healing accompanied by decreased accumulation of myeloid-derived suppressor
cell (MDSCs). (a) KLF4 IHC staining in skin of RosaCreER/KLF4(flox) mice without (KLF4þ /þ ) and with tamoxifen induction (KLF4 / ). The areas between two
dotted red lines delineate skin suprabasal layers. (b) Quantitative real-time reverse-transcriptase–PCR to analyze the expression of KLF4 and CCR2. (c) Wound
healing phenotypes (left, n¼ 10) and the wound size quantification (right). (d) IHC staining of a-SMA and COL1A1 in KLF4þ /þ and KLF4 / mice at day 3
after wound induction. (e) Flow cytometry using anti-Ly6G and anti-CD11b antibodies with spleen cells and single skin cells. Representative images from one
of five mice in each group are shown (a, c, and d). Scale bars: 50mm. Mean±SEM. *Po 0.05, **Po 0.01, and ***Po 0.001. IHC, Immunohistochemistry;
KLF4, Kruppel-like factor 4; and MDSCs, myeloid-derived suppressor cell.
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infiltrated lymphocytes in the granule tissue of the skin in
KLF4 / (FSP-1) mice were almost doubled compared with
those in WT mice, suggesting an increased inflammatory
status in KLF4 / (FSP-1) mice (Figure 5b). Consistent with
decreased populations of CCR2þ MDSCs and COL1A1þ
CD45þCD11bþ fibrocytes in the BM KLF4 knockout mice
with a full-thickness wound, the numbers of these cells were
also reduced in FSP-1-Cre/KLF4(flox) mice in the PU model
(Figure 5c). In parallel with the increased inflammation in
KLF4 / (FSP-1) mice, the populations of CD11bþ Ly6Cþ
þ cells, which may represent the inflammatory monocytes
(Robbins and Swirski, 2010), in blood and the skin
wound were increased compared with those in WT mice
(Figure 5d). In addition, the fact that FSP-1 expression was
significantly reduced in the wound in KLF4 / (FSP-1) mice
(Figure 5e) is consistent with KLF4 role in regulating FSP-1 (Shi
et al., 2014).
Activation of KLF4 by Mexicanin I increased CCR2þ MDSCs
and fibrocytes in the mouse PU model accompanied by elevated
gene expression of CCR2 and FSP-1
To further confirm the role of KLF4 in the PU healing process,
we tested the plant-derived sesquiterpene lactone, Mexicanin I,
which is known to be a c-Myb inhibitor (Bujnicki et al., 2012).
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Figure 2. Delayed wound healing in bone marrow Kruppel-like factor 4 (KLF4) knockout mice and a compromised accumulation of CCR2þmyeloid-derived
suppressor cell (MDSCs) and fibrocytes. (a) Chimeric mice receiving bone marrow cells from Rosa26CreER/KLF4(flox)/b-actin-EGFP donor mice were used.
Quantification of the wound size in each group of mice is shown (n¼ 10). (b) Single cells from the skin wound were gated by c. They were examined by CD11b and
Ly6G antibodies, followed by further analysis using a CCR2 antibody. Representative contour plots in each group are shown. (c) Similar to (b), except that COL1A1,
CD45, and CD11b antibodies were used to analyze the fibrocytes. (d) Representative immunofluorescent staining of the wounds with a-SMA and COL1A1 antibodies.
Yellow arrows indicate EGFP/a-SMA or EGFP/COL1A1 coexpressing cells (scale bars: 50mm). KLF4, Kruppel-like factor 4; MDSCs, myeloid-derived suppressor cell.
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Figure 3. Kruppel-like factor 4 (KLF4)-expressing bone marrow cells are
integrated into the healing tissue and colocalized with a-SMA-expressing
cells. Chimeric mice were generated by bone marrow transplantation using
bone marrow cells from C57BL/6 mice (control) or KLF4/EGFP mice into
C57BL/6 recipient mice. An 8-mm-diameter full-thickness wound was
placed and the wound beds were collected 4 days later, followed by
immunofluorescence staining with an anti-a-SMA antibody. Representative
colocalization of EGFP cells with red a-SMA-expressing cells in the healing
tissue (left) is indicated by white arrowheads (n¼5). Scale bars: 25mm. KLF4,
Kruppel-like factor 4.
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c-Myb activates the proto-oncogene c-Myc (Neiman et al.,
2003) that may inhibit the tumor suppressor KLF4. As shown
in Figure 6a, Mexicanin I, at a 50 nM concentration, promoted
fibrocyte generation from mouse spleen cells, which was
accompanied by the upregulation of KLF4. In the mouse PU
model, we found that Mexicanin I significantly accelerated
wound healing (Figure 6b). In addition, although the total
populations of MDSCs or CCR2þ MDSCs in blood with and
without Mexicanin I treatment in control mice did not show
any significant differences (Figure 6c and data not shown),
COL1A1þCD45þCD11bþ fibrocytes and CD11bþ
Ly6Cþ þ inflammatory monocytes were increased following
a PU induction in naı¨ve and Mexicanin I-treated mice.
Importantly, in the skin wounds, CCR2þ MDSCs and fibro-
cytes were increased in the Mexicanin I-treated mice from
1.36 to 2.55% for CCR2þ MDSCs and from 1.70 to 3.31%
for fibrocytes. In line with the accelerated wound healing,
the CD11bþ Ly6Cþ þ monocytes in the skin were
decreased from 5.11% in the control mice to 2.75% in the
Mexicanin I-treated mice (Figure 6c). Consistently, there was
minimal change of infiltrated lymphocytes in Mexicanin
I-treated mice following PU induction, but a significant
increase in untreated control mice (Figure 6d). In parallel
with the changes of CCR2þ MDSCs and fibrocytes, expres-
sion levels of KLF4, FSP-1, CCL2, and CCR2 were all
significantly increased in the wounds after Mexicanin I
treatment (Supplementary Figure 2 online). Most importantly,
there were no significant differences in the wound healing
kinetics, numbers of CCR2þ MDSCs, fibrocytes, and
CD11bþ Ly6Cþ þ monocytes between Mexicanin I-treated
mice and untreated mice in KLF4 / (FSP-1) mice following
PU induction (Figure 6e).
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DISCUSSION
In this study, by using two different mouse models of wound
healing, we demonstrated that KLF4 promotes healing by
regulating the recruitment of monocytic MDSCs and their
subsequent differentiation into fibrocytes. This concept is
consistent with the current wound healing model in which
the inflammatory response wanes before the proliferation
of fibroblasts and keratinocytes. Thus we have shown that
MDSCs have a dual role by regulating the inflammation as an
immunosuppressive and by promoting cell proliferation after
they differentiate into fibrocytes (Figure 6f).
Initially, the decreased recruitment of CCR2þ MDSCs into
the wound of KLF4 knockout mice (Figure 2b) raised a
concern that the decreased number of fibrocytes may not be
because of the subsequent transdifferentiation of these
MDSCs; i.e., the relative importance of transdifferentiation
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was questionable. However, our data suggest that KLF4
controls both the recruitment of MDSCs and their subsequent
transdifferentiation. First, KLF4 deficiency in BM decreased the
expression of CCR2 ((Alder et al., 2008) and Figure 1b). It is
known that CCL2/CCR2 signaling has a critical role in
cutaneous wound healing (Gillitzer and Goebeler, 2001),
and it is confirmed by elevated CCL2 expression following
PU induction in our study (Figure 5e). Second, we recently
reported that KLF4 deficiency in CCR2þ MDSCs attenuated
fibrocyte generation and resulted in compromised tumor
metastasis (Shi et al., 2014). The role of KLF4 in fibrocyte
generation was also supported by Mexicainin I-mediated KLF4
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Figure 6. Kruppel-like factor 4 (KLF4) activation by Mexicanin I accelerated pressure ulcer (PU) wound healing accompanied by increased CCR2þmyeloid-
derived suppressor cell (MDSCs) and fibrocytes. (a) Fibrocyte generation in the presence of 50 nM Mexicanin I (left), KLF4 expression detected by western
blotting (middle) and quantitative real-time reverse-transcriptase–PCR (right). CXCR4 and b-actin were used as controls. (b) Measurement of wound healing kinetics
after Mexicanin I treatment (n¼10). (c) Flow cytometry analysis to examine different cell types. (d) Representatives of HE staining of the skin wounds (left)
and numbers of infiltrated lymphocytes in the arbitrary squares with the same sizes from the left (right). (e) (left) Measurement of wound healing kinetics in
KLF4 / (FSP-1) mice (n¼ 10), and (right) flow cytometry analysis. (f) Proposed function of KLF4-mediated fibrocyte generation in wound healing. Scale bar:
100mm, *Po0.05. HE staining, hematoxylin and eosin staining; KLF4, Kruppel-like factor 4; MDSCs, myeloid-derived suppressor cell; and PU, pressure ulcer.
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activation and fibrocyte generation (Figure 6a). Third, and
most importantly, in FSP-1-Cre/KLF4(flox) mice, the basal level
of CCR2þ MDSCs in the blood was increased (Figure 5c).
However, this population was significantly decreased in the
wound. The increased basal level of CCR2þ MDSCs most
likely reflected the developmental regulation of these cells by
KLF4. It is also supported by our ELISA data (Figure 4e). Levels
of colony-stimulating factor, macrophage inflammatory pro-
tein 1 alpha, IL4, and IL5 were increased, but IP-12(P40) level
was decreased, in KLF4 knockout mice. High levels of colony-
stimulating factor are correlated with the conversion of
BM-derived MDSCs from CCR2þ MDSCs to neutrophils
(Sawanobori et al., 2008). High macrophage inflammatory
protein 1 alpha expression was associated with CD49d (a
marker of CCR2þ MDSCs (Haile et al., 2010))-mediated
monocyte migration (Chuluyan et al., 1995). Increased
colony-stimulating factor and macrophage inflammatory
protein 1 alpha suggests that KLF4 regulates the develop-
ment of CCR2þMDSCs. In addition, given the role of IL4 and
IL5 in the polarization of Th2 cells (Ansel et al., 2006) and the
role of IL-12(P40) in the polarization of Th1 cells (Torti and
Feldman, 2007), alterations in the levels of these cytokines
suggest that KLF4 ablation promotes Th2 cell polarization.
The critical role of KLF4 in monocytic MDSCs in cutaneous
wound healing is not only supported by using the mouse
model with KLF4 deficiency in the BM (Figure 2) but also by
using the FSP-1-Cre/KLF4(flox) mice with KLF4 deficiency in
CCR2þ MDSCs (Figure 5). However, there is one limitation
in our FSP-1-Cre/KLF4(flox) mouse model. FSP-1 is expressed
in multiple cell types including monocytes (Cabezon et al.,
2007) and fibroblasts (Strutz et al., 1995), and therefore we
cannot exclude the contribution of KLF4-regulated fibroblasts
in wound healing. Future experiments will be performed to
specifically test the effect of BM CCR2þ MDSCs on wound
healing. Similarly, we plan to test the fibroblast-specific effect
of KLF4 on wound healing. In addition, the molecular
mechanisms by which KLF4 regulates FSP-1 expression will
be further determined.
Our data showed that Mexicanin I activated KLF4 and
accelerated PU wound healing (Figure 6). Although we
favored a KLF4- and fibrocyte-mediated mechanism, KLF4-
independent effects of Mexicanin I should also be considered.
Furthermore, pharmacological kinetics of Mexicanin I will be
determined in wound healing.
Collectively, this study not only confirms a critical role of
KLF4 in wound healing but also warrants the future develop-
ment of KLF4-based therapeutic strategies, such as activation
of KLF4 by Mexicanin I in the treatment of patients with PUs.
MATERIALS AND METHODS
Generation of KLF4-deficient mice
Rosa26CreER/KLF4(flox) mice and Fsp-1-Cre/KLF4 (flox) mice were
generated by crossing Rosa26CreER (NCI, Frederick, MD, Stock#:
01XAB) and Fsp-1-Cre (Jackson, Bar Harbor, ME, Stock#: 012641)
with KLF4(flox) mice, respectively. Rosa26CreER/KLF4(flox)/b-actin-
EGFP mice were generated by crossing Rosa26CreER/KLF4(flox) mice
with b-actin-EGFP mice (Jackson, Stock#: 006567). KLF4 knockout in
RosaCre26ER/KLF4(flox) mice was induced by daily intraperitoneal
injection of tamoxifen (TAM, Sigma-Aldrich, St. Louis, MO, 50 mg/kg)
for 5 consecutive days. Sunflower seed oil was used as a control.
Mice were bred and used in specific pathogen-free facilities accord-
ing to the Animal Care and Use Committee Guidelines of the
University of South Carolina. In the wound healing model, the
control and mutant mice were littermates with mixed sex at a similar
6- to 8-week age range.
Bone marrow transplantation
Six-week-old C57BL/6 recipient mice were lethally irradiated
(900 rad). The donor cells were harvested from the long bones of
RosaCre26ER/KLF4 (flox)/b-actin-EGFP or KLF4/EGFP mice, and
3 106 nucleated cells were injected retro-orbitally into each
recipient mouse. After repopulation success was established, KLF4
knockout was induced as described above.
Wound healing mouse models and Mexicanin I treatment
The full-thickness wound healing model was created as previously
described (Li et al., 2012). Before the placement of the wound, the
mice were administered anesthesia by IP injection of ketamine
(100 mg/kg) and xylazine (12.5 mg/kg). The time when tissue was
removed was considered day 0 and the healing wounds were
photographed on days 1, 3, 5, 7, and 9. The edges of the wound
were circled and quantified by Image J and expressed as a fraction of
initial area. Ten mice each in KLF4þ /þ and KLF4 / groups were
used to measure the relative wound areas at different time points.
The mouse PU model was created as reported (Stadler et al., 2004).
Mexicanin I treatment consisted of an intraperitoneal injection every
other day at a concentration of 0.38 mg/kg mice (Jodynis-Liebert
et al., 2000). The injection was started one day before the first
ischemia/reperfusion cycle until the end of third ischemia/reperfusion
when the mice were killed.
Fibrocyte generation
The splenocytes of Babl/c WT mice were purified and subjected to
fibrocyte generation by using a developed approach with the
application of IL-13 (50 ng/ml) and M-CSF (25 ng/ml) (Crawford
et al., 2010). Three days later, the cells were stained with a Hema
3 staining kit (Fisher Scientific, Waltham, MA) and the numbers of
fibrocytes were counted. A concentration of 50 nM Mexicanin I was
used in the experimental group and DMSO (Sigma-Aldrich) was used
in the control group.
Immunohistochemistry (IHC) and immunofluorescence (IF)
staining
IHC and IF were performed by using standard protocols with sections
from the skin wounds. The following antibodies were used: rabbit
anti-mouse KLF4 antibody (1:100), rabbit anti-mouse FSP-1 antibody
(1:100) and rabbit anti-mouse a-SMA antibody (1:100, both from
Abcam), and rabbit anti-mouse Collagen Type I alpha 1 antibody
(COL1A1, 1:200, Rockland, Gilbertsville, PA).
Western blotting
Protein from skin tissues and cultured cells was extracted for western
blotting, as described (Ai et al., 2007). Primary antibodies were rabbit
anti-mouse KLF4 (1:1000, GenSpin, Milano, Italy), rabbit anti-mouse
CXCR4 (1:1000, eBioscience, San Diego, CA), and rat anti-mouse
b-actin (1:1000, Sigma-Aldrich).
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RNA extraction and real-time PCR analysis
Total RNA was prepared using Trizol Reagent (Invitrogen, Grand
Island, NY) according to the manufacturer’s instructions. First-strand
cDNA synthesis and real-time PCR were carried out as described (Li
et al., 2012). Primer sequences for real-time PCR are listed in Supple-
mentary Table S1 online.
Flow cytometry
Spleen and BM were prepared as described previously (Yu et al.,
2013). The peripheral blood monocytes were isolated using
Histoplaque (Sigma-Aldrich). Wound sites were minced and digested
with 1.0 mg/ml collagenase (Sigma-Aldrich) to generate a single-cell
suspension and purified by using a Percoll gradient (Sigma-Aldrich).
These dissociated single cells were stained with fluorochrome-
conjugated antibodies specific for mouse CD11b, Ly6G, CD45
(eBioscience), and CCR2 (R&D). For COL1A1 intracellular staining,
cells were harvested, stained with surface markers, fixed with a fixation
solution (eBioscience) for 15 min, permeabilized with ice-cold pure
methanol for 30 min, and incubated with biotin-conjugated mouse
COL1A1 antibody (Rockland) and fluorochrome-conjugated stre-
ptavidin (eBioscience). Flow cytometry was performed using FACS
Aria II (BD bioscience, Franklin Lakes, NJ), and data were analyzed
with Flowjo (Ashland, OR).
Quantification and statistical analysis
KLF4-positive brown cells in suprabasal layers of each arbitrarily
defined high magnified field were counted by Image J. Three different
high magnified fields were counted for each animal. Each group
consisted of five mice. Epidermal thickness, numbers of hair follicles,
and infiltrated lymphocytes were similarly quantified. Data were
represented as mean±SEM. Data were analyzed using the following
tests: t-test (two-group comparison) and one-way analysis of variance
(multigroup comparison). A P-value o0.05 was considered to
indicate statistical significance.
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